Table 1

Enrolment of minority groups in Phase III trials of SLE2 3 9 10 14

TrialnLocation of trial sites% African% AI/AN% Hispanic
BLyS 72819North America, Europe141321
BLyS 56865Asia, South America43249
Tabalumab2288Worldwide111329
Embody1584Worldwide12Unknown20
  • AI,¬†American Indian; AN, Asian.